glp-1 agonist joint pain Osteoarthritis treatment via the GLP-1–mediated gut-joint axis targets intestinal FXR signaling GLP-1 Medications: Everything You Need

And for individuals with a history of using substances or medications to manage weight, GLP-1 misuse is an emerging and real concern

Accelerate refers to increasing dose intensity when clinical indicators suggest that stronger receptor activation may be appropriate

This means ~7m annual revenue per DiGA

TGF-1 also inhibits the activity of P450 aromatase, an enzyme that converts androgen to estrogen (240, 281)

Post-market surveillance and real-world data from millions of GLP-1 prescriptions have not identified a widespread gastroparesis epidemic

Perspective on the Rx Pipeline: Diabetes and GLP-1 Agonists Situation Summary Initial therapy for individuals with T2DM who are at high risk for CVD, heart failure (HF) and/or chronic kidney disease is metformin and a glucagon-like peptide 1 (GLP-1) or sodium glucose transporter ligand 2 (SGLT-2)